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cm2 before to 1*86(0*39) cm2 after dilatation (p = 0.0001) and then decreased to 1.72(0-39) cm2 at follow up (p < 0.001); mitral valve area (Doppler) increased from 1 01 (0.24) to 1*89 (0*42) cm2 (p = 0.0001) and then decreased to 1.78(0-40) cm2 (p < 005). The overall restenosis rate was 15% and over 900/ of the patients were free from cardiovascular events. Age, valvar calcification, echocardiographic score, and mitral valve area after dilatation were found to be determinant predictors of restenosis. In patients who underwent recatheterisation, mitral valve area by the Gorlin method at follow up was comparable with that by plDanimetry and Doppler methods whereas a significant discrepancy between the three methods was noted immediately after dilatation. The severity of mitral regurgitation before and after dilatation was determined by ventriculography and was graded on a 0 + (no regurgitation) to 4 + (severe) scale according to the degree of opacification of the left atrium and pulmonary veins. 10 The degree of valvar calcification was graded fluoroscopically from 0 + (no calcium) to 4 + (dense valvar and subvalvar calcium). On the basis of calcification, patients were separated into two groups: group 1, 0 or 1 +; group 2, 2, 3, or 4 +. The severity of leaflet immobility, valve thickness, calcification, and submitral involvement was assessed by echocardiography and each feature was graded on a score of 0 to 4 +; higher scores represented more abnormal structure. The total echo score was the sum of the four scores."1 12 Restenosis was defined as a decrease in mitral valve area >50% from the original gain together with mitral valve area <1*5 cm2 at follow up and that at follow up was significant, the area at follow up was still significantly larger than that before dilatation as determined by both planimetry and Doppler; and 134 (76%) patients still had a mitral valve area > 1-5 cm2 at follow up. Restenosis had developed in 26 (15%) patients. Seven variables-age, sex, heart rhythm, NYHA functional class before dilatation, echocardiographic score, valvar calcification, and mitral valve area after dilatation-were used in the Cox proportional hazard regression model to determine which factors may affect restenosis. Mitral valve area after dilatation (p = 0-0001) and echo score (p < 0-01) were shown to be significant predictors for restenosis by multivariate analysis. Univariate analysis identified age, valvar calcification, echo score, and mitral valve area after dilatation as significant determinants of restenosis (table 1). Figure 1 shows the cumulative % of survival without restenosis and cardiac events during a five year follow up by Kaplan-Meier analysis.
When patients were separated according to the degree of valvar calcification, 91 were in Figure 3 Restenosis seems to be highly related to the patient's baseline characteristics-namely, old age, heavy valvar calcification, high mitral valve echo score, and suboptimal initial results. Furthermore, restenosis seems to be a continuous process and is likely to increase gradually with time. The time to restenosis is difficult to predict and therefore a serial clinical and Doppler echocardiographic follow up is necessary to detect early restenosis.
Anatomical restenosis as determined by Doppler echocardiography was not always associated with recurrent symptoms. In our study 27% of the patients with restenosis were still in NYHA functional class I. This indicates that the rate of restenosis in our series would be much lower than 15% if we only considered the symptomatic patients and those in whom a second balloon dilatation of the mitral valve or surgery were required. These were the criteria for restenosis in previous reports after closed and open surgical commissurotomy. John It is important to note that atrial septal defects and significant mitral regurgitation as seen in some patients after balloon dilatation of the mitral valve seem to recede at follow up. Atrial septal defect was detected by colour Doppler in only 6% of the patients at follow up and has not required surgical repair by itself in our experience. Also, mitral regurgitation seems to decrease or remain unchanged at follow up in most of our patients. The few patients in whom mitral valve replacement for severe mitral regurgitation was necessary during the follow up period already had significant mitral insufficiency immediately after the procedure.
The question of whether or not a repeat catheterisation needs to be undertaken after balloon dilatation of the mitral valve is becoming much less controversial. In fact, Block et al reported that the discrepancies of mitral valve area immediately after dilatation between the Gorlin method and Doppler echocardiography was not found at follow up.7 Our results corroborate those findings that suggest that repeat catheterisation is not necessary to evaluate these patients at follow up. Doppler echocardiography is an accurate and reliable tool for follow up of these patients in addition to the clinical evaluation. Furthermore, the difference in cost between catheterisation and Doppler echocardiography is obvious. For all these reasons, we think that a repeat catheterisation is indicated only in selected patients to solve possible discrepancies between clinical and Doppler echocardiographic findings.
Mitral valve areas as determined by echo planimetry and Doppler pressure half time are often consistent, but discrepancies are sometimes encountered. We recommend for that reason to rely on the same method to determine restenosis.
LIMITATIONS OF THE STUDY
The major limitation of this study is that we were only able to have follow up Doppler echocardiographic studies in 176 patients, which is 35% of our total patient population undergoing balloon dilatation of the mitral valve. These patients who had follow up may still be considered as a representative sample because their age, sex, severity of clinical symptoms, valvar calcification, echo score, cardiac rhythm, mitral valve area, and degree of mitral regurgitation before and after balloon dilatation of the mitral valve were similar to those of the rest of our patient population.
Another important limitation which should be noted is that although the study period was over five years, the mean follow up period was less than two years. This may cause underestimation of survival rates without restenosis and cardiovascular events because of the small sample size after that period.
In conclusion from our study we are able to show that balloon dilatation of the mitral valve provides encouraging late success that compares well to that found in patients undergoing surgical mitral commissurotomy. Old age, heavy calcification, high echo score, and suboptimal initial results are important risk factors for restenosis. Larger numbers of patients and longer follow up periods are required to determine the long-term efficacy of balloon dilatation of the mitral valve.
